More pharmaceutical companies may be implicated in price fixing -Cancer Alliance

On Tuesday the Competition Commission confirmed its launched an investigation into pharmaceutical companies, including Aspen, Pfizer and Roche for their suspected excessive pricing of life saving cancer medication.

Roche is being investigated for it's alleged over pricing of breast cancer medication and Pfizer for lung cancer medication.

Aspen is also being probed for suspected abuse of dominance by charging excessive prices in the provision of cancer medication.

The Cancer Alliance which has lobbied around the exorbitant pricing of medicines.

Xolani Gwala spoke to the alliance's Salome Meye.

Not even the department of health can afford paying R 125 000 as oppose to R 500 000 for public patients.

Salome Meye, Member of the Cancer Alliance (Part of the Fix the Patent Laws Coalition)

We know the cost of manufacturing the drugs is half of what they are offering the department of health for the same drug, one really needs to ask who is making the money and who is benefiting, certainly not the patients in the public or private sector.

Salome Meye, Member of the Cancer Alliance (Part of the Fix the Patent Laws Coalition)

We also have knowledge of other drugs and other companies that we will take to the competition commission to investigate.

Salome Meye, Member of the Cancer Alliance (Part of the Fix the Patent Laws Coalition)

Click on the link below to listen to the full audio...


This article first appeared on 702 : More pharmaceutical companies may be implicated in price fixing -Cancer Alliance


CapeTalk welcomes all comments that are constructive, contribute to discussions in a meaningful manner and take stories forward.

However, we will NOT condone the following:

  • Racism (including offensive comments based on ethnicity and nationality)
  • Sexism
  • Homophobia
  • Religious intolerance
  • Cyber bullying
  • Hate speech
  • Derogatory language
  • Comments inciting violence.

We ask that your comments remain relevant to the articles they appear on and do not include general banter or conversation as this dilutes the effectiveness of the comments section.

We strive to make the CapeTalk community a safe and welcoming space for all.

CapeTalk reserves the right to: 1) remove any comments that do not follow the above guidelines; and, 2) ban users who repeatedly infringe the rules.

Should you find any comments upsetting or offensive you can also flag them and we will assess it against our guidelines.

CapeTalk is constantly reviewing its comments policy in order to create an environment conducive to constructive conversations.

Read More
[LISTEN] Sapo-Sassa deal moves one step forward - Mark Barnes

[LISTEN] Sapo-Sassa deal moves one step forward - Mark Barnes

Sapo will now be handling the core functions of the new social grants system.

Political Desk:  NDPP ruling demonstrates Zuma's delaying tactics - Karima Brown

Political Desk: NDPP ruling demonstrates Zuma's delaying tactics - Karima Brown

On Friday, the High Court ordered that President Jacob Zuma have no say in the appointment of a new NDPP.

Sassa and Sapo deal indicates a commitment to court ruling  - Jeff Radebe

Sassa and Sapo deal indicates a commitment to court ruling - Jeff Radebe

Sapo and the South African Social Security Agency (Sassa) have signed a landmark deal.

Disgruntled Free State ANC members may be heading to court again

Disgruntled Free State ANC members may be heading to court again

The group wants the outcomes of the provincial conference to be declared null and void.

Words you will hear today: Nieheritance

Words you will hear today: Nieheritance

Khabazela (Jonathan Fairbairn) shares the latest addition to his dictionary.

Three pharmaceutical companies probed for excessive pricing of cancer drugs

Three pharmaceutical companies probed for excessive pricing of cancer drugs

The three companies being investigated by the Competition Commission are generic Aspen Pharmacare, Roche and Pfizer.

Popular articles
[LISTEN] 'We are dealing with an outbreak of Listeriosis' - Dr Thomas

[LISTEN] 'We are dealing with an outbreak of Listeriosis' - Dr Thomas

Head of the Centre for Enteric Diseases at the NICD Dr Thomas says that Listeriosis is problematic because it isn’t notifiable.

Publisher saves South African students billions with free textbooks

Publisher saves South African students billions with free textbooks

This year we're going to hit a million downloads of free textbooks in SA - James van der Westhuizen, country manager for Bookboon.

Steinhoff money woes and why you should care

Steinhoff money woes and why you should care

The company lost around R100 billion leaving the JSE reeling in one of the biggest private sector business scandals.

Few retirement funds unaffected by Steinhoff implosion (i.e. you just got had)

Few retirement funds unaffected by Steinhoff implosion (i.e. you just got had)

Your money, and Steinhoff… Bruce Whitfield interviews Certified Financial Planner Peter Calitz.

‘There were clear warning signs at Steinhoff. All of which fund managers missed’

‘There were clear warning signs at Steinhoff. All of which fund managers missed’

The Money Show’s Bruce Whitfield interviews Sygnia Group CEO Magda Wierzycka.

Zille: 40 000 affordable housing units in the pipeline for WC

Zille: 40 000 affordable housing units in the pipeline for WC

Western Cape Premier Helen Zille says the government plays a crucial role in the provision of affordable housing in the province.

How businessman Max Lichaba struck gold with his jewellery company

How businessman Max Lichaba struck gold with his jewellery company

Entrepreneur Max Lichaba built his own empire and is the CEO of Lichaba Creations and several other businesses. This is his story.